Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Loading

William Dai

AddedMar 31, 2024

UpdatedMay 31, 2026

William Dai

William Dai

Board Member, Meditrina

Crunchbase LinkedIn

William Dai's Career

Meditrina

San Jose, CA, US

Board Member· Board

Laplace Interventional

Laplace Interventional

Plymouth, MN, US

Board Member· Board

Aqua Medical

Santa Ana, CA, US

Board Member· Board

Luminopia

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

William Dai's Career

Meditrina

Series A$28.2M332016San Jose, CA, US

Board Member· Board

Leadership at Meditrina

Csaba TruckaiFounder & CEO

Similar to Meditrina

Minerva SurgicalSanta Clara, CA, USMedical Devicesest. 2008Minerva SurgicalSanta Clara, CA, US · est. 2008

US-based Minerva offers a comprehensive suite of devices for minimally invasive treatment of Abnormal Uterine Bleeding.

Public · $173.9M189

Avana HealthLexington, KY, USMedical Devices, Treatmentsest. 2021Avana HealthLexington, KY, US · est. 2021

Avana Health: Innovating women's health with uterine treatment platforms and drug-device systems.

IntraVuRedwood City, CA, USMedical Imagingest. 2015IntraVuRedwood City, CA, US · est. 2015

IntraVu offers a compact, high-resolution, single-use imaging system for minimally invasive medical procedures.

Series B · $26.5M13

Mirabilis MedicaBothell, WA, USMedical Devicesest. 2006Mirabilis MedicaBothell, WA, US · est. 2006

Mirabilis Medica designs therapeutic ultrasound devices for uterine fibroids treatment in the US.

Angel · $29.1M8

Laplace Interventional

Laplace Interventional

Series B$20.8M112020Plymouth, MN, US

Board Member· Board

Leadership at Laplace Interventional

Ramji IyerFounder

Similar to Laplace Interventional

TriFlo CardiovascularNewport Beach, CA, USMedical Devicesest. 2017TriFlo CardiovascularNewport Beach, CA, US · est. 2017

TriFlo Cardiovascular: Biotech firm specializing in minimally invasive heart valve treatments.

Series B · $14.7M8

VdyneMaple Grove, MN, USMedical Devicesest. 2017VdyneMaple Grove, MN, US · est. 2017

Vdyne: A Minnesota-based medical organization innovating in tricuspid valve replacement and repair technology.

Series C · $13.2M6

InterValveMinnetonka, MN, USMedical Devicesest. 2004InterValveMinnetonka, MN, US · est. 2004

InterValve, Inc.: US and Belgium-based manufacturer of innovative medical devices for aortic treatments.

Seed · $14.1M30

Opus Medical TherapiesAtlanta, GA, USMedical Devicesest. 2014Opus Medical TherapiesAtlanta, GA, US · est. 2014

Opus Medical Therapies: Innovating transcatheter mitral and tricuspid valve replacements.

Seed · $4.7M11

Aqua Medical

Series B$11.3M52016Santa Ana, CA, US

Board Member· Board

Leadership at Aqua Medical

Hazim AnsariCo-Founder

Lloyd MencingerCEO

Virender SharmaCo-Founder

Similar to Aqua Medical

Aqua HeartSanta Ana, CA, USMedical Devicesest. 2017Aqua HeartSanta Ana, CA, US · est. 2017

AQUA Heart, Inc.: A leading MedTech firm in Santa Ana, CA, innovating in cardiovascular care and AF therapy.

Francis MedicalMaple Grove, MN, USMedical Devicesest. 2018Francis MedicalMaple Grove, MN, US · est. 2018

Francis Medical: Innovating therapeutic solutions for prostate, kidney, and bladder cancer.

Series B · $77M42

Avantis Medical SystemsSan Jose, CA, USMedical Devicesest. 2004Avantis Medical SystemsSan Jose, CA, US · est. 2004

Avantis Medical Systems: Innovating in catheter-based endoscopic devices for GI tract abnormalities detection and treatment.

Series A · $57.6M32

Aerwave MedicalNaples, FL, USMedical Devicesest. 2020Aerwave MedicalNaples, FL, US · est. 2020

Aerwave Medical: Pioneering non-drug COPD and asthma treatments since 2020, based in New York.

Luminopia

Series A$33.1M342015Cambridge, MA, US

Board Member· Board

Leadership at Luminopia

Mark JacobsteinBoard Member

Scott XiaoCo-Founder

Dean TraversBoard Member

Bob LangerBoard Member

Alex WendlandCo-Founder

Similar to Luminopia

LumiTheraPoulsbo, WA, USMedical Devicesest. 2013LumiTheraPoulsbo, WA, US · est. 2013

LumiThera, Inc.: Innovating non-invasive ocular devices for treating acute and chronic eye disorders.

Series A · $36.5M19

i-Lumen ScientificBloomington, MN, USMedical Devices, Therapeuticsest. 2015i-Lumen ScientificBloomington, MN, US · est. 2015

i-Lumen Scientific: Innovating noninvasive therapies for dry age-related macular degeneration.

Series B · $18.8M5

Vivid VisionSan Francisco, CA, USVision Tests, Vision Trainingest. 2014Vivid VisionSan Francisco, CA, US · est. 2014

Vivid Vision: Pioneering unique vision tests and treatments with cutting-edge technology.

Series A · $2.9M31

OculoMotor TechnologiesNewark, DE, USDiagnostics, Vision Therapyest. 2018OculoMotor TechnologiesNewark, DE, US · est. 2018

Oculomotor Technologies: Providing vision therapy tools for optometry practices.

Pre-Seed · $1.2M6

William Dai's Similar Executives & Operators

Jay Geoffrey WacherBoard Member · Bukalapak

Soemantri BrodjonegoroBoard Member · Bukalapak

Lau Eng BoonBoard Member · Bukalapak

WILL WEI CHENGBoard Member · DiDi

Dhirubhai H. AmbaniBoard Member · Reliance Retail

Mason YeoBoard Member · Kakao

JaeHong ChoiBoard Member · Kakao

Yun SeokBoard Member · Kakao

People Similar to William Dai

Shaw WarrenCo-Founder · Setpoint Medical

Murthy SimhambhatlaCEO · Setpoint Medical

Sean WhiteCo-Founder · Cactus Medical

David W. AndersonBoard Member · Molecular Detection

Weiliam ChenBoard Member · Endomedix

Jeff TerrellBoard Member · Boomerang Medical